Group 1 - The vitamin sector experienced a strong upward movement at the beginning of trading on November 24, with notable gains in several companies [2] - Harbin Sanlian reached the daily limit increase, while Jinshi Yao surged over 7% and Guangji Pharmaceutical rose more than 6% [2] - Other companies such as Shuoshi Biological, Meinong Biological, and Hendi Pharmaceutical also saw increases in their stock prices [2]

数据显示，国泰基金旗下1只基金位居美农生物十大流通股东。国泰中证畜牧养殖ETF（159865）三季 度增持33.45万股，持有股数115.59万股，占流通股的比例为1.55%。根据测算，今日浮亏损失约119.06 万元。 国泰中证畜牧养殖ETF（159865）成立日期2021年3月1日，最新规模60.97亿。今年以来收益14.05%， 同类排名3172/4208；近一年收益10.32%，同类排名3087/3972；成立以来亏损35.31%。 国泰中证畜牧养殖ETF（159865）基金经理为梁杏。 11月21日，美农生物跌5.13%，截至发稿，报19.06元/股，成交1.16亿元，换手率7.79%，总市值26.83亿 元。 资料显示，上海美农生物科技股份有限公司位于上海市嘉定区沥红路151号，成立日期1997年10月14 日，上市日期2022年6月17日，公司主营业务涉及饲料添加剂及酶解蛋白饲料原料的研发、生产、销 售。主营业务收入构成为：功能性饲料添加剂58.94%，营养性饲料添加剂21.25%，酶解蛋白饲料原料 13.33%，浓缩饲料5.53%，其他(补充)0.94%。 从美农生物十大流通股东角度 截至发稿 ...

Group 1: Company Overview and Growth Strategy - The company has achieved double-digit growth in revenue and profit for the first three quarters, driven by a focus on product innovation and market expansion [2][3] - The company implements a "product-leading, value service, partner growth" strategy, emphasizing product development and market penetration [3][4] - The company has established a comprehensive marketing network across China and is expanding internationally, particularly in countries along the "Belt and Road" initiative [3][4] Group 2: International Market Strategy - The company has developed a mature internationalization strategy over 20 years, focusing on selecting quality distributors and providing comprehensive services to partners [4][5] - The company has established sales networks in over 40 countries and regions, enhancing its brand image and market share [4][5] - Future plans include expanding direct sales models and becoming a global resource integration platform for the livestock industry [5] Group 3: Customer Structure and Value Proposition - The main customers include feed production companies, breeding enterprises, and distributors, with notable clients such as Haida Group and New Hope [5][6] - The company has built a robust marketing management system and a customer-centric value service system to enhance customer loyalty [5][6] Group 4: Pricing and Product Line Management - Pricing strategies are based on market conditions, competition, and customer negotiations, ensuring flexibility and responsiveness [6][7] - The company focuses on a diverse product line supported by core technologies, emphasizing research and development to meet various customer needs [6][7] Group 5: Operational Efficiency and Digitalization - The company has implemented automated production lines and digital management systems to enhance operational efficiency [7][8] - Investments in smart manufacturing and customer relationship management systems aim to improve responsiveness to customer needs [7][8] Group 6: Future Development Plans - The company aims to become a global leader in animal nutrition technology, focusing on both domestic and international market expansion [9] - Plans include continuous product innovation and addressing industry challenges to improve animal production performance and food safety [9] - The company emphasizes talent development through internal training and external recruitment to build a strong workforce [9]

Group 1 - The chemical products sector increased by 0.41% on November 19, with Dongyue Silicon Materials leading the gains [1] - The Shanghai Composite Index closed at 3946.74, up 0.18%, while the Shenzhen Component Index closed at 13080.09, unchanged [1] - Key stocks in the chemical products sector showed significant price increases, with Dongyue Silicon Materials rising by 10.94% to a closing price of 16.13 [1] Group 2 - The chemical products sector experienced a net outflow of 1.034 billion yuan from institutional investors, while retail investors saw a net inflow of 1.228 billion yuan [2] - Major stocks like Hesheng Silicon Industry and Morning Light New Materials had varying net inflows and outflows from different investor types [3] - Hesheng Silicon Industry had a net inflow of 25.5 million yuan from institutional investors, while retail investors experienced a net outflow of 46.52 million yuan [3]

Group 1 - The core point of the article highlights the recent performance of Meino Biological, which saw a stock price increase of 6.99%, reaching 20.36 CNY per share, with a total market capitalization of 2.866 billion CNY [1] - Meino Biological specializes in the research, production, and sales of feed additives and enzymatic protein feed materials, with its main business revenue composition being functional feed additives (58.94%), nutritional feed additives (21.25%), enzymatic protein feed materials (13.33%), concentrated feed (5.53%), and others (0.94%) [1] Group 2 - From the perspective of major circulating shareholders, Guotai Fund's ETF, Guotai Zhongzheng Livestock Breeding ETF (159865), increased its holdings by 334,500 shares, now holding a total of 1,155,900 shares, which accounts for 1.55% of the circulating shares [2] - The Guotai Zhongzheng Livestock Breeding ETF has a current scale of 6.097 billion CNY, with a year-to-date return of 14.49% and a one-year return of 12.63% [2]

证券代码：301156 证券简称：美农生物 公告编号：2025-063 （一）会议召开时间： 1、现场会议时间：2025 年 11 月 12 日 14:40 2、网络投票时间：通过深圳证券交易所系统进行网络投票的具体时间为 2025 年 11 月 12 日 9:15-9:25，9:30-11:30，13:00-15:00；通过深圳证券交易 所互联网投票系统进行投票的具体时间为 2025 年 11 月 12 日 9:15 至 15:00 的任 意时间。 （二）召开地点：上海市嘉定区沥红路 151 号 公司会议室 上海美农生物科技股份有限公司 2025 年第二次临时股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东会不存在否决议案的情形； 2、本次股东会不涉及变更以往股东会已通过的决议。 一、会议召开和出席情况 （三）召开方式：现场表决与网络投票相结合 （1）现场投票：包括本人出席及授权他人出席 （2）网络投票：公司通过深圳证券交易所交易系统和互联网投票系统向股 东提供网络形式的投票平台，公司股东应在本通知列明的有关时限内通过 ...

北京市天元律师事务所 关于上海美农生物科技股份有限公司 2025 年第二次临时股东会的 法律意见 京天股字（2025）第 691 号 致：上海美农生物科技股份有限公司 上海美农生物科技股份有限公司（以下简称"公司"）2025 年第二次临时股东 会（以下简称"本次股东会"）采用现场投票与网络投票相结合的方式召开，现场会 议于 2025 年 11 月 12 日 14:40 在上海市嘉定区沥红路 151 号公司会议室召开。北 京市天元律师事务所（以下简称"本所"）接受公司聘任，指派本所律师参加本次股 东会现场会议，并根据《中华人民共和国公司法》、《中华人民共和国证券法》（以 下简称"《证券法》"）、《上市公司股东会规则》（以下简称"《股东会规则》"） 以及《上海美农生物科技股份有限公司章程》（以下简称"《公司章程》"）等有关 规定，就本次股东会的召集、召开程序、出席会议人员的资格、召集人资格、会议 表决程序和表决结果等有关事宜出具本法律意见。 为出具本法律意见，本所律师审查了《上海美农生物科技股份有限公司第五届 董事会第十五次会议决议公告》《上海美农生物科技股份有限公司关于召开 2025 年第二次临时股东会的通知》 ...

Core Viewpoint - The company aims to become a global leader in animal nutrition technology, focusing on both domestic and international market expansion [2] Group 1: Market Strategy - The company has established a sales network in over 40 countries and regions, gaining a first-mover advantage in the industry [2] - The market strategy emphasizes "deepening domestic operations while breaking into international markets" [2] Group 2: Financial Performance - In the first half of 2025, the company's overseas business revenue increased by over 20% year-on-year, indicating a continued growth trend [2] Group 3: Future Outlook - The company plans to continue investing in international market development to enhance its competitive advantage globally [2]

Core Viewpoint - The company emphasizes "innovation-driven development" and focuses on product and technology innovation to address industry pain points and enhance animal production performance while ensuring food safety [1] Group 1: Company Strategy - The company is committed to the development and application research of efficient, safe, and environmentally friendly feed additives and enzymatic protein feed raw materials [1] - The company has been exploring enzymatic technology for various non-grain protein sources such as cottonseed protein, soybean protein, and corn protein [1] Group 2: Product Advantages - Enzymatic protein raw materials have advantages over traditional protein sources in terms of protein digestion and absorption efficiency, as well as improving animal physiological functions [1]

Market Overview - The chemical products sector increased by 1.38% on October 29, with JinHua New Materials leading the gains [1] - The Shanghai Composite Index closed at 4016.33, up 0.7%, while the Shenzhen Component Index closed at 13691.38, up 1.95% [1] Top Performers - JinHua New Materials (Code: 920015) closed at 62.92, up 30.00% with a trading volume of 135,600 shares and a turnover of 746 million [1] - WeiLan Bio (Code: 603739) closed at 15.51, up 10.00% with a trading volume of 96,900 shares and a turnover of 148 million [1] - YiNuoWei (Code: 920261) closed at 16.34, up 7.08% with a trading volume of 48,000 shares and a turnover of 75.93 million [1] Underperformers - XianFeng New Materials (Code: 300163) closed at 4.61, down 7.62% with a trading volume of 1,672,400 shares and a turnover of 787 million [2] - JinJi Co., Ltd. (Code: 300798) closed at 7.63, down 5.92% with a trading volume of 230,600 shares and a turnover of 178 million [2] - KaiLi New Materials (Code: 6888889) closed at 41.10, down 5.30% with a trading volume of 40,900 shares and a turnover of 170 million [2] Capital Flow - The chemical products sector experienced a net outflow of 84.36 million from institutional investors, while retail investors saw a net inflow of 87.49 million [2][3] - Major stocks like KaiMeiTeQi (Code: 002549) had a net inflow of 200 million from institutional investors, while DeMeiHuaGong (Code: 002054) saw a net outflow of 155 million [3]